Adam B. Glick - Publications

Affiliations: 
Pennsylvania State University, State College, PA, United States 
Area:
Immunology, Cell Biology, Oncology

81 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Chalmers FE, Mogre S, Rimal B, Son J, Patterson AD, Stairs DB, Glick AB. The unfolded protein response gene Ire1α is required for tissue renewal and normal differentiation in the mouse tongue and esophagus. Developmental Biology. 492: 59-70. PMID 36179879 DOI: 10.1016/j.ydbio.2022.09.009  0.32
2022 Mogre S, Blazanin N, Walsh H, Ibinson J, Minnich C, Andrew Hu CC, Glick AB. TGFβ1 regulates HRas-mediated activation of IRE1α through the PERK-RPAP2 axis in keratinocytes. Molecular Carcinogenesis. 61: 958-971. PMID 35975910 DOI: 10.1002/mc.23453  0.325
2022 Chalmers FE, Dusold JE, Shaik JA, Walsh HA, Glick AB. Targeted deletion of TGFβ1 in basal keratinocytes causes profound defects in stratified squamous epithelia and aberrant melanocyte migration. Developmental Biology. 485: 9-23. PMID 35227671 DOI: 10.1016/j.ydbio.2022.02.009  0.318
2020 Liu Y, Bailey JT, Abu-Laban M, Li S, Chen C, Glick AB, Hayes DJ. Photocontrolled miR-148b nanoparticles cause apoptosis, inflammation and regression of Ras induced epidermal squamous cell carcinomas in mice. Biomaterials. 256: 120212. PMID 32736169 DOI: 10.1016/J.Biomaterials.2020.120212  0.436
2020 Chalmers FE, Stairs DB, Glick AB. Abstract 5839: The unfolded protein response gene Ire1α is required for tissue renewal and normal differentiation in the mouse tongue and esophagus Cancer Research. 80: 5839-5839. DOI: 10.1158/1538-7445.Am2020-5839  0.402
2019 Chalmers F, Mogre S, Son J, Blazanin N, Glick AB. The multiple roles of the unfolded protein response regulator IRE1α in cancer. Molecular Carcinogenesis. PMID 31041814 DOI: 10.1002/Mc.23031  0.338
2017 Smith KJ, Boyer JA, Muku GE, Murray IA, Gowda K, Desai D, Amin SG, Glick AB, Perdew GH. Ah receptor activation potentiates neutrophil chemoattractant (C-X-C motif) ligand 5 expression in keratinocytes and skin. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 28973351 DOI: 10.1093/Toxsci/Kfx160  0.402
2017 Blazanin N, Son J, Craig-Lucas AB, John CL, Breech KJ, Podolsky MA, Glick AB. ER stress and distinct outputs of the IRE1α RNase control proliferation and senescence in response to oncogenic Ras. Proceedings of the National Academy of Sciences of the United States of America. PMID 28847931 DOI: 10.1073/Pnas.1701757114  0.407
2017 Wu HJ, Oh JW, Spandau DF, Tholpady S, Diaz J, Schroeder LJ, Offutt CD, Glick AB, Plikus MV, Koyama S, Foley J. Estrogen modulates mesenchymal-epidermal interactions in the adult nipple. Development (Cambridge, England). PMID 28289136 DOI: 10.1242/Dev.141630  0.36
2017 Podolsky MA, Bailey JT, Gunderson AJ, Oakes CJ, Breech K, Glick AB. Differentiated state of initiating tumor cells is key to distinctive immune responses seen in H-RasG12V-induced squamous tumors. Cancer Immunology Research. PMID 28137717 DOI: 10.1158/2326-6066.Cir-16-0304  0.778
2017 Glick AB, Bailey JT, Gunderson A, Breech K, Podolsky M. Abstract 2673: Divergent therapeutic responses to CD40L blockade or CD40 activation in Ras-driven skin cancers determined by origin of tumor initiating cell Cancer Research. 77: 2673-2673. DOI: 10.1158/1538-7445.Am2017-2673  0.776
2015 van den Bogaard EH, Podolsky MA, Smits JP, Cui X, John C, Gowda K, Desai D, Amin SG, Schalkwijk J, Perdew GH, Glick AB. Genetic and pharmacological analysis identifies a physiological role for the AHR in epidermal differentiation. The Journal of Investigative Dermatology. 135: 1320-8. PMID 25602157 DOI: 10.1038/Jid.2015.6  0.37
2015 Podolsky MA, Oakes CJ, Gunderson A, Breech K, Bailey J, Glick AB. Abstract 530: Location of oncogene expression within a stratified squamous epithelium drives distinct B and CD4 T-cell crosstalk to dictate the tumor immune response Cancer Research. 76: 530-530. DOI: 10.1158/1538-7445.Am2016-530  0.782
2014 Zhu B, Ferry CH, Markell LK, Blazanin N, Glick AB, Gonzalez FJ, Peters JM. The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress. The Journal of Biological Chemistry. 289: 20102-19. PMID 24898257 DOI: 10.1074/Jbc.M114.551069  0.725
2014 Ravindran A, Mohammed J, Gunderson AJ, Cui X, Glick AB. Tumor-promoting role of TGFβ1 signaling in ultraviolet B-induced skin carcinogenesis is associated with cutaneous inflammation and lymph node migration of dermal dendritic cells. Carcinogenesis. 35: 959-66. PMID 24363069 DOI: 10.1093/Carcin/Bgt486  0.78
2014 Zhu B, Ferry CH, Blazanin N, Bility MT, Khozoie C, Kang BH, Glick AB, Gonzalez FJ, Peters JM. PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling. Oncogene. 33: 5348-59. PMID 24213576 DOI: 10.1038/Onc.2013.477  0.4
2014 Podolsky MA, Gunderson A, Breech K, Glick AB. Abstract 4083: Opposing roles of B cells in Ras-driven squamous tumor development dependent on tissue compartment of oncogene expression and tumor phenotype Cancer Research. 74: 4083-4083. DOI: 10.1158/1538-7445.Am2014-4083  0.778
2014 Blazanin N, John C, Craig-Lucas A, Glick A. Abstract 2257: Divergent IRE1α endonuclease outputs dictate the senescence response of mouse keratinocytes to oncogenic HRAS Cancer Research. 74: 2257-2257. DOI: 10.1158/1538-7445.Am2014-2257  0.521
2013 Hogan KA, Ravindran A, Podolsky MA, Glick AB. The TGFβ1 pathway is required for NFκB dependent gene expression in mouse keratinocytes. Cytokine. 64: 652-9. PMID 24075100 DOI: 10.1016/J.Cyto.2013.09.004  0.43
2013 Gunderson AJ, Mohammed J, Horvath FJ, Podolsky MA, Anderson CR, Glick AB. CD8(+) T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-γ. The Journal of Investigative Dermatology. 133: 955-63. PMID 23151849 DOI: 10.1038/Jid.2012.390  0.749
2013 Mohammed J, Gunderson AJ, Khong HH, Koubek RD, Udey MC, Glick AB. TGFβ1 overexpression by keratinocytes alters skin dendritic cell homeostasis and enhances contact hypersensitivity Journal of Investigative Dermatology. 133: 135-143. PMID 22832490 DOI: 10.1038/Jid.2012.241  0.729
2012 Glick AB. The Role of TGFβ Signaling in Squamous Cell Cancer: Lessons from Mouse Models. Journal of Skin Cancer. 2012: 249063. PMID 23326666 DOI: 10.1155/2012/249063  0.402
2012 Plichta KA, Mathers JL, Gestl SA, Glick AB, Gunther EJ. Basal but not luminal mammary epithelial cells require PI3K/mTOR signaling for Ras-driven overgrowth. Cancer Research. 72: 5856-66. PMID 23010075 DOI: 10.1158/0008-5472.Can-12-1635  0.37
2012 Shi C, Cooper TK, McCloskey DE, Glick AB, Shantz LM, Feith DJ. S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion. Carcinogenesis. 33: 1310-8. PMID 22610166 DOI: 10.1093/Carcin/Bgs184  0.501
2012 Zhu B, Khozoie C, Bility MT, Ferry CH, Blazanin N, Glick AB, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor β/δ cross talks with e2f and attenuates mitosis in HRAS-expressing cells Molecular and Cellular Biology. 32: 2065-2082. PMID 22473992 DOI: 10.1128/Mcb.00092-12  0.391
2012 Glick A. A new xenotransplantation model reveals tumor-initiating cells in cutaneous squamous cell carcinoma Journal of Investigative Dermatology. 132: 261-262. PMID 22241440 DOI: 10.1038/Jid.2011.327  0.456
2012 Zhu B, Khozoie C, Ferry CH, Markell LM, Bility MT, Blazanin N, Glick AB, Gonzalez FJ. Abstract 2172: Anti-oncogenic role of peroxisome proliferator-activated receptor-α/β (PPARδ/α) involves inhibition of mitosis and regulation of Hras1-induced senescence Cancer Research. 72: 2172-2172. DOI: 10.1158/1538-7445.Am2012-2172  0.365
2011 Mordasky Markell L, Masiuk KE, Blazanin N, Glick AB. Pharmacologic inhibition of ALK5 causes selective induction of terminal differentiation in mouse keratinocytes expressing oncogenic HRAS Molecular Cancer Research. 9: 746-756. PMID 21521744 DOI: 10.1158/1541-7786.Mcr-11-0112  0.486
2011 Zhu B, Khozoie C, Bility M, Blazanin N, Glick AB, Gonzalez FJ, Peters JM. Abstract 1227: Anti-oncogenic role of Peroxisome proliferator-activated receptor- β/Δ (Pparβ/Δ) involves regulation of viral Hras1 (v-Hras1)-induced senescence and endoplasmic reticulum (ER) stress in mouse primary keratinocytes Cancer Research. 71: 1227-1227. DOI: 10.1158/1538-7445.Am2011-1227  0.403
2010 Mordasky Markell L, Pérez-Lorenzo R, Masiuk KE, Kennett MJ, Glick AB. Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression. Carcinogenesis. 31: 2127-35. PMID 20852150 DOI: 10.1093/Carcin/Bgq191  0.528
2010 Koesters R, Kaissling B, LeHir M, Picard N, Theilig F, Gebhardt R, Glick AB, Hähnel B, Hosser H, Gröne HJ, Kriz W. Tubular overexpression of transforming growth factor-β1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells American Journal of Pathology. 177: 632-643. PMID 20616344 DOI: 10.2353/Ajpath.2010.091012  0.337
2010 Mohammed J, Ryscavage A, Perez-Lorenzo R, Gunderson AJ, Blazanin N, Glick AB. TGFΒ1-induced inflammation in premalignant epidermal squamous lesions requires IL-17 Journal of Investigative Dermatology. 130: 2295-2303. PMID 20410912 DOI: 10.1038/Jid.2010.92  0.758
2010 Pérez-Lorenzo R, Markell LM, Hogan KA, Yuspa SH, Glick AB. Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis. Carcinogenesis. 31: 1116-23. PMID 20172950 DOI: 10.1093/Carcin/Bgq041  0.555
2010 Markell LM, Pérez-Lorenzo R, Masiuk KE, Kennett MJ, Glick AB. Use of a TGFβ type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFβ signaling in tumor promotion and progression Carcinogenesis. 31: 2127-2135. DOI: 10.1093/carcin/bgq191  0.437
2009 Ponnamperuma RM, King KE, Elsir T, Glick AB, Wahl GM, Nister M, Weinberg WC. The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-β-mediated growth regulation Journal of Pathology. 219: 263-274. PMID 19718706 DOI: 10.1002/Path.2600  0.347
2009 Jabbar SF, Abrams L, Glick A, Lambert PF. Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene. Cancer Research. 69: 4407-14. PMID 19435895 DOI: 10.1158/0008-5472.Can-09-0023  0.311
2009 Rozenberg J, Rishi V, Orosz A, Moitra J, Glick A, Vinson C. Inhibition of CREB function in mouse epidermis reduces papilloma formation Molecular Cancer Research. 7: 654-664. PMID 19435810 DOI: 10.1158/1541-7786.Mcr-08-0011  0.423
2009 Bae DS, Blazanin N, Licata M, Lee J, Glick AB. Tumor suppressor and oncogene actions of TGFbeta1 occur early in skin carcinogenesis and are mediated by Smad3. Molecular Carcinogenesis. 48: 441-53. PMID 18942075 DOI: 10.1002/Mc.20482  0.438
2009 Zheng T, Oh MH, Oh SY, Schroeder JT, Glick AB, Zhu Z. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. The Journal of Investigative Dermatology. 129: 742-51. PMID 18830273 DOI: 10.1038/Jid.2008.295  0.39
2009 Vijayachandra K, Higgins W, Lee J, Glick A. Induction of p16ink4a and p19ARF by TGFβ1 contributes to growth arrest and senescence response in mouse keratinocytes Molecular Carcinogenesis. 48: 181-186. PMID 18655107 DOI: 10.1002/Mc.20472  0.468
2008 Yang SH, Andl T, Grachtchouk V, Wang A, Liu J, Syu LJ, Ferris J, Wang TS, Glick AB, Millar SE, Dlugosz AA. Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/beta3-catenin signaling. Nature Genetics. 40: 1130-5. PMID 19165927 DOI: 10.1038/Ng.192  0.393
2008 Bility MT, Devlin-Durante MK, Blazanin N, Glick AB, Ward JM, Kang BH, Kennett MJ, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) inhibits chemically induced skin tumorigenesis Carcinogenesis. 29: 2406-2414. PMID 18799709 DOI: 10.1093/Carcin/Bgn219  0.408
2008 Traykova-Brauch M, Schönig K, Greiner O, Miloud T, Jauch A, Bode M, Felsher DW, Glick AB, Kwiatkowski DJ, Bujard H, Horst J, von Knebel Doeberitz M, Niggli FK, Kriz W, Gröne HJ, et al. An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice. Nature Medicine. 14: 979-84. PMID 18724376 DOI: 10.1038/Nm.1865  0.308
2008 Shukla A, Ho Y, Liu X, Ryscavage A, Glick AB. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-β1 signaling: Role in skin carcinogenesis Molecular Cancer Research. 6: 509-516. PMID 18337457 DOI: 10.1158/1541-7786.Mcr-07-0396  0.437
2008 Glick AB, Perez-Lorenzo R, Mohammed J. Context-dependent regulation of cutaneous immunological responses by TGFβ1 and its role in skin carcinogenesis Carcinogenesis. 29: 9-14. PMID 17893229 DOI: 10.1093/Carcin/Bgm215  0.45
2008 Garcia RJ, Ittah A, Mirabal S, Figueroa J, Lopez L, Glick AB, Kos L. Endothelin 3 induces skin pigmentation in a keratin-driven inducible mouse model Journal of Investigative Dermatology. 128: 131-142. PMID 17611578 DOI: 10.1038/Sj.Jid.5700948  0.41
2007 Marie YS, Toulon A, Paus R, Maubec E, Cherfa A, Grossin M, Descamps V, Clemessy M, Gasc JM, Peuchmaur M, Glick A, Farman N, Jaisser F. Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia American Journal of Pathology. 171: 846-860. PMID 17675581 DOI: 10.2353/Ajpath.2007.060991  0.377
2007 Glick A, Ryscavage A, Perez-Lorenzo R, Hennings H, Yuspa S, Darwiche N. The high-risk benign tumor: Evidence from the two-stage skin cancer model and relevance for human cancer Molecular Carcinogenesis. 46: 605-610. PMID 17538943 DOI: 10.1002/Mc.20345  0.39
2006 Kirshner J, Jobling MF, Pajares MJ, Ravani SA, Glick AB, Lavin MJ, Koslov S, Shiloh Y, Barcellos-Hoff MH. Inhibition of transforming growth factor-β1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress Cancer Research. 66: 10861-10869. PMID 17090522 DOI: 10.1158/0008-5472.Can-06-2565  0.386
2006 Gerdes MJ, Myakishev M, Frost NA, Rishi V, Moitra J, Acharya A, Levy MR, Park SW, Glick A, Yuspa SH, Vinson C. Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Research. 66: 7578-88. PMID 16885357 DOI: 10.1158/0008-5472.Can-06-1247  0.536
2006 Abdel-Fattah R, Glick A, Rehman I, Maiberger P, Hennings H. Methylation of the O6-Methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol International Journal of Cancer. 118: 527-531. PMID 16094607 DOI: 10.1002/Ijc.21316  0.414
2005 Suh KS, Mutoh M, Gerdes M, Crutchley JM, Mutoh T, Edwards LE, Dumont RA, Sodha P, Cheng C, Glick A, Yuspa SH. Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth. Cancer Research. 65: 562-71. PMID 15695400  0.325
2005 Glick AB, Yuspa SH. Tissue homeostasis and the control of the neoplastic phenotype in epithelial cancers Seminars in Cancer Biology. 15: 75-83. PMID 15652452 DOI: 10.1016/J.Semcancer.2004.08.008  0.449
2005 Hutchin ME, Kariapper MS, Grachtchouk M, Wang A, Wei L, Cummings D, Liu J, Michael LE, Glick A, Dlugosz AA. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes & Development. 19: 214-23. PMID 15625189 DOI: 10.1101/Gad.1258705  0.489
2004 Chu EY, Hens J, Andl T, Kairo A, Yamaguchi TP, Brisken C, Glick A, Wysolmerski JJ, Millar SE. Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development (Cambridge, England). 131: 4819-29. PMID 15342465 DOI: 10.1242/Dev.01347  0.375
2004 Sauer B, Vogler R, von Wenckstern H, Fujii M, Anzano MB, Glick AB, Schäfer-Korting M, Roberts AB, Kleuser B. Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. The Journal of Biological Chemistry. 279: 38471-9. PMID 15247277 DOI: 10.1074/Jbc.M313557200  0.334
2004 Woodworth CD, Michael E, Smith L, Vijayachandra K, Glick A, Hennings H, Yuspa SH. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte Carcinogenesis. 25: 1771-1778. PMID 15105299 DOI: 10.1093/Carcin/Bgh170  0.403
2004 Glick AB. TGFβ1, back to the future: Revisiting its role as a transforming growth factor Cancer Biology and Therapy. 3: 276-283. PMID 15034302 DOI: 10.4161/Cbt.3.3.849  0.475
2003 Vijayachandra K, Lee J, Glick AB. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model Cancer Research. 63: 3447-3452. PMID 12839923  0.31
2001 Liu X, Alexander V, Vijayachandra K, Bhogte E, Diamond I, Glick A. Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proceedings of the National Academy of Sciences of the United States of America. 98: 9139-44. PMID 11481479 DOI: 10.1073/Pnas.161016098  0.414
2001 Yamada H, Vijayachandra K, Penner C, Glick AB. Increased sensitivity of TGFβ1 null cells to alkylating agents reveals a novel link between TGFβ signaling and O6-methylguanine methyltransferase promoter hypermethylation Journal of Biological Chemistry. 276: 19052-8. PMID 11262404 DOI: 10.1074/Jbc.M100615200  0.302
2000 Diamond I, Owolabi T, Marco M, Lam C, Glick A. Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. The Journal of Investigative Dermatology. 115: 788-94. PMID 11069615 DOI: 10.1046/J.1523-1747.2000.00144.X  0.352
2000 Tremain R, Marko M, Kinnimulki V, Ueno H, Bottinger E, Glick A. Defects in TGFβ signaling overcome senescence of mouse keratinocytes expressing v-ras(Ha) Oncogene. 19: 1698-1709. PMID 10763827 DOI: 10.1038/Sj.Onc.1203471  0.385
1999 Glick A, Popescu N, Alexander V, Ueno H, Bottinger E, Yuspa SH. Defects in transforming growth factor-β signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes Proceedings of the National Academy of Sciences of the United States of America. 96: 14949-14954. PMID 10611318 DOI: 10.1073/Pnas.96.26.14949  0.359
1999 Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nature Cell Biology. 1: 260-6. PMID 10559937 DOI: 10.1038/12971  0.343
1998 Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, Tennant RW, Weinberg RA, Yuspa SH, Conti CJ. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo Genes and Development. 12: 2469-2474. PMID 9716400 DOI: 10.1101/Gad.12.16.2469  0.43
1998 Glick AB, Diamond I, Owolabi T, Lam C. Tetracycline regulated gene expression in the epidermis of transgenic mice expressing the tTA transactivator Journal of Dermatological Science. 16: S134. DOI: 10.1016/S0923-1811(98)83801-2  0.332
1997 Rutberg SE, Lee EJ, Hansen LH, Glick AB, Yuspa SH. Identification of differentially expressed genes in chemically induced skin tumors. Molecular Carcinogenesis. 20: 88-98. PMID 9328439 DOI: 10.1002/(Sici)1098-2744(199709)20:1<88::Aid-Mc10>3.0.Co;2-5  0.455
1996 Dlugosz AA, Glick AB, Tennenbaum T, Weinberg WC, Yuspa SH. Isolation and utilization of epidermal keratinocytes for oncogene research. Methods in Enzymology. 254: 3-20. PMID 8531694 DOI: 10.1016/0076-6879(95)54003-2  0.401
1995 Tennenbaum T, Belanger AJ, Glick AB, Tamura R, Quaranta V, Yuspa SH. A splice variant of α6 integrin is associated with malignant conversion in mouse skin tumorigenesis Proceedings of the National Academy of Sciences of the United States of America. 92: 7041-7045. PMID 7624366 DOI: 10.1073/Pnas.92.15.7041  0.451
1995 Ueda M, Kawamura H, Sutter C, Glick A, Yuspa SH, Strickland JE. Analysis of v-Ha-ras and v-fos oncogene transduction into a mouse epidermal cell line with "initiated" phenotype in culture but normal skin phenotype in vivo Molecular Carcinogenesis. 13: 96-103. PMID 7605585 DOI: 10.1002/Mc.2940130206  0.407
1994 Yuspa SH, Dlugosz AA, Cheng CK, Denning MF, Tennenbaum T, Glick AB, Weinberg WC. Role of oncogenes and tumor suppressor genes in multistage carcinogenesis Journal of Investigative Dermatology. 103. PMID 7963691 DOI: 10.1038/Jid.1994.16  0.48
1994 Glick AB, Lee MM, Darwiche N, Kulkarni AB, Karlsson S, Yuspa SH. Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes & Development. 8: 2429-40. PMID 7958907 DOI: 10.1101/Gad.8.20.2429  0.427
1993 Hennings H, Glick AB, Greenhalgh DA, Morgan DL, Strickland JE, Tennenbaum T, Yuspa SH. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 202: 1-8. PMID 8424089 DOI: 10.3181/00379727-202-43511A  0.466
1993 Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis. 14: 2353-8. PMID 8242866 DOI: 10.1093/Carcin/14.11.2353  0.404
1993 Glick AB, Kulkarni AB, Tennenbaum T, Hennings H, Flanders KC, O'Reilly M, Sporn MB, Karlsson S, Yuspa SH. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proceedings of the National Academy of Sciences of the United States of America. 90: 6076-80. PMID 7687059 DOI: 10.1073/Pnas.90.13.6076  0.382
1993 Tennenbaum T, Weiner AK, Belanger AJ, Glick AB, Hennings H, Yuspa SH. The suprabasal expression of a6β4 integrin predicts a high risk for malignant progression in mouse skin carcinogenesis Journal of Dermatological Science. 6: 8. DOI: 10.1016/0923-1811(93)90810-C  0.333
1991 Wakefield L, Kim SJ, Glick A, Winokur T, Colletta A, Sporn M. Regulation of transforming growth factor-beta subtypes by members of the steroid hormone superfamily. Journal of Cell Science. Supplement. 13: 139-48. PMID 2084113 DOI: 10.1242/Jcs.1990.Supplement_13.13  0.316
1991 Glick AB, Sporn MB, Yuspa SH. Altered regulation of TGF-β1 and TGF-α in primary keratinocytes and papillomas expressing v-Ha-ras Molecular Carcinogenesis. 4: 210-219. PMID 2064727 DOI: 10.1002/Mc.2940040308  0.369
1990 Glick AB, Danielpour D, Morgan D, Sporn MB, Yuspa SH. Induction and autocrine receptor binding of transforming growth factor-β2 during terminal differentiation of primary mouse keratinocytes Molecular Endocrinology. 4: 46-52. PMID 2157977 DOI: 10.1210/Mend-4-1-46  0.303
1987 Lumadue JA, Glick AB, Ruddle FH. Cloning, sequence analysis, and expression of the large subunit of the human lymphocyte activation antigen 4F2 Proceedings of the National Academy of Sciences of the United States of America. 84: 9204-9208. PMID 3480538 DOI: 10.1073/Pnas.84.24.9204  0.304
Show low-probability matches.